Treatment
Treatment A clinical trials
We’re tracking 8,322 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT06787144RecruitingPhase 1
Studying ELVN-001 for Japanese adults with CML
This trial tests a new drug called ELVN-001 for people with chronic myeloid leukemia (CML) who have not responded to or could not take at least two prior treatments. It's for Japanese patients, including those with a specific genetic change (T315I mutation). The goal is to see if ELVN-001 can help control the leukemia.
Akita, AkitaAges 18 years+ - NCT06873841Recruiting
Cognitive therapy with or without biofeedback for tics in teens and young adults
This trial tests a talking therapy that helps manage tics by changing thoughts and feelings. Some people also get biofeedback, which uses sensors to help control body responses. Researchers want to see which approach works better for reducing tics in teens and young adults with Tourette's syndrome or bothersome tics.
Montreal, QuebecAges 14–21 - NCT06869057Recruiting
Improving diabetes care after hospital discharge
This study tests a redesigned discharge process to help people with type 2 diabetes manage their health after leaving the hospital. It focuses on patients who also have unmet social needs, like food or housing issues.
Worcester, MassachusettsAges 18 years+ - NCT06874894Enrolling by invitation
Blood Thinner Safety in Asians With Atrial Fibrillation
This study is looking at how blood thinners work in Asian people with atrial fibrillation. It aims to better understand the balance between preventing strokes and the risk of bleeding.
GwangmyeongAges 1.5 years+ - NCT06869213RecruitingPhase 2
Adebrelimab plus chemo before and after surgery for esophageal cancer
This trial tests a combination of the immunotherapy drug adebrelimab (SHR-1316) and chemotherapy given before and after surgery for locally advanced esophageal squamous cell carcinoma that can be removed. The goal is to see if this approach helps shrink the tumor and improves outcomes.
BeijingAges 18–75 - NCT06872593Recruiting
Driving simulator test for sleepiness in sleep apnea
This study tests a new driving simulator test (like a video game) to measure daytime sleepiness, compared to the standard sleepiness test. It looks at people with sleep apnea who temporarily stop using their CPAP machine, to see if the new test is accurate.
Zurich, ZRHAges 18 years+ - NCT06876896Recruiting
Pressure inside belly during pulse field ablation for A-fib
This study looks at how pulse field ablation (a heart procedure for irregular heartbeats) affects pressure inside the belly. If you have atrial fibrillation or atrial flutter and are planning to have this procedure, your participation may help doctors understand how to make it safer.
Winston-Salem, North CarolinaAges 18 years+ - NCT06872034Recruiting
Can Venostan reduce swelling after ankle fracture surgery?
This trial tests an oral medication called Venostan to see if it helps reduce swelling after ankle fracture surgery. If you have a broken ankle and are planning to have surgery to fix it, this study may be a good fit.
BeijingAges 18 years+ - NCT06873009Enrolling by invitation
Can therapy help men in prison quit smoking?
This trial tests if cognitive behavioural therapy (a type of talk therapy that changes thinking and habits) can help men in prison stop smoking. It aims to see what works best and for whom.
Paris, Île-de-France RegionAges 18 years+ - NCT06871410RecruitingPhase 1
Engineered immune cells for relapsed or refractory AML
This trial tests a new type of cell therapy called CD83 CAR T cells for people whose acute myeloid leukemia (AML) has come back or hasn't responded to treatment. These cells are designed to find and attack the leukemia cells while sparing healthy cells.
Buffalo, New YorkAges 18 years+ - NCT06875063RecruitingPhase 1
CAR-T cell therapy for CD19-positive relapsed B-cell lymphoma
This trial tests a new CAR-T cell therapy (a type of immune cell treatment) for patients with a specific kind of B-cell lymphoma that has come back or not responded to previous therapy. The treatment targets a protein called CD19 on the cancer cells to help your immune system fight the lymphoma.
Xiamen, FujianAges 18–70 - NCT06870409RecruitingPhase 3
Phages plus antibiotics for heart infection treatment
This trial tests if adding bacteriophages (viruses that kill bacteria) to standard antibiotic treatment can help people with a serious heart valve infection called infective endocarditis. It may offer a new way to fight the infection.
MoscowAges 18 years+ - NCT06876350Recruiting
Wood cast vs. thermoplastic splint after thumb surgery
This trial compares two types of casts used after thumb joint replacement surgery to see which one works better for recovery. Participation lasts about 6 weeks.
Tampa, FloridaAges 18 years+ - NCT06874491Recruiting
Breathing treatment fun for kids 4-6
This study tests if special distractions can help young children feel more comfortable during their first breathing treatment. If your child is 4 to 6 years old and otherwise healthy, they might be able to join.
ErzurumAges 4–6 - NCT06879145RecruitingPhase 2/Phase 3
Study of SHR-A2102 and Adebrelimab for muscle-invasive bladder cancer
This trial tests a combination of two drugs, SHR-A2102 and Adebrelimab, for people with muscle-invasive bladder cancer that hasn't spread. The goal is to see if this treatment can help control the cancer.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06488300RecruitingPhase 2
Testing antiviral treatments for early RSV
This trial tests if antiviral medications can help adults with early respiratory syncytial virus (RSV) feel better faster. It is for people aged 18 to 64 who have had RSV symptoms for 4 days or less and have tested positive for the virus.
VientianeAges 18–64 - NCT06594588Recruiting
Aerobic exercise for depression in adults
This trial tests whether adding a personalized aerobic exercise program to your usual depression treatment can help you feel better. It is for adults aged 18-45 with depression who are not currently in regular psychotherapy.
Beijing, Beijing MunicipalityAges 18–45 - NCT06859424RecruitingPhase 2
Testing a new GVHD prevention method after donor stem cell transplant
This trial tests a new way to prevent graft-versus-host disease (a common side effect of stem cell transplant) using a drug called cyclophosphamide after transplant. It is for adults with certain blood cancers who need a transplant from a partially matched unrelated donor.
Birmingham, AlabamaAges 18–66 - NCT06868277RecruitingPhase 3
Comparing two drugs for first-line treatment of advanced lung cancer
This trial tests a new drug called Rilvegostomig against the standard drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer that has high levels of PD-L1 protein. The goal is to see which drug works better as a first treatment before any other cancer therapy.
La Mesa, CaliforniaAges 18 years+ - NCT06859866Recruiting
Light therapy for gum disease around dental implants
This trial tests whether a special light treatment (photodynamic therapy) you can use at home can help reduce inflammation around dental implants (peri-implant mucositis). It's designed for people with early gum problems around implants, before they get worse.
RomaAges 18 years+ - NCT06863987Enrolling by invitationPhase 3
Valsartan oral solution for high blood pressure in children
This trial tests if an oral solution of valsartan safely lowers blood pressure in children and teens ages 6 to 17. It may be an option if your child has high blood pressure and qualifies based on age, weight, and blood pressure level.
Linyi, ShandongAges 6–17 - NCT06862557Recruiting
PEMF treatment for people with dementia
This study tests whether a pulsed electromagnetic field (PEMF) device can help people with mild to moderate Alzheimer's or related dementias. If you or a loved one has memory loss, this trial looks at a potential new way to support brain health without medication.
Boca Raton, FloridaAges 50–100 - NCT06863272RecruitingPhase 1/Phase 2
Study of ifinatamab deruxtecan for advanced prostate cancer
This trial tests a new drug, ifinatamab deruxtecan, either alone or in combination with other treatments, for men with metastatic castrate-resistant prostate cancer that has worsened despite hormone therapy. It aims to see if this approach can help shrink or slow the cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT06865105RecruitingPhase 2
Targeted treatments for active psoriatic arthritis
This study tests targeted medications for people with active psoriatic arthritis (PsA) who have already tried 1 or 2 other advanced treatments without success or couldn't tolerate them. The goal is to see if these newer options can better control joint pain and skin symptoms.
Huntington Beach, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,322 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.